Analytical specification
| Vial size | 20 mg |
|---|---|
| CAS number | 85806-95-7 |
| Molecular formula | C12H19N3O8 |
| Molecular weight | 333.29 g/mol |
| Sequence | Ala-Glu-Asp |
| Physical form | Lyophilized powder |
| Storage | -20 °C, protected from light |
$55.00
No certificate of analysis is published for this compound. The certificates we hold are published in full on the verification page.
Molecular data, handling and published literature
Lyophilized Cartalax, 20 mg per vial. Supplied for in-vitro laboratory research.
Only 5 left in stock
Intended Use: This product is sold exclusively for laboratory research and analytical use. It is strictly prohibited to use this compound for human consumption, ingestion, or application.
Buying 10 or more? Contact us for wholesale inquiries
| Vial size | 20 mg |
|---|---|
| CAS number | 85806-95-7 |
| Molecular formula | C12H19N3O8 |
| Molecular weight | 333.29 g/mol |
| Sequence | Ala-Glu-Asp |
| Physical form | Lyophilized powder |
| Storage | -20 °C, protected from light |
Cartalax supplied as a lyophilized solid in a sealed 20 mg vial for in-vitro laboratory research.
Store at -20 °C, protected from light. Reconstitution, where required, is performed in the laboratory against the researcher’s own protocol.
For Research Use Only. Not for Human Consumption.